Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suicide nanoplasmids coding for ribosome-inactivating proteins.

Hardy Mitdank1, Meike Tröger1, Alexander Sonntag1

  • 1Freie Universität Berlin, Institut für Pharmazie, Königin-Luise-Str. 2+4, 14195 Berlin, Germany.

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|December 27, 2021
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolite profiling and in vitro assessment of skin-related pharmacological activities in Baccharis trimera (Less.) DC.

Journal of ethnopharmacology·2026
Same author

German soils affect biomass production, elemental profiles, and anti-inflammatory activity of three medicinal plants used in Brazilian traditional medicine: Scoparia dulcis L., Physalis angulata L., and Porophyllum ruderale (Jacq.) Cass.

Scientific reports·2026
Same author

Non-Temperature-Induced Antitumor Effects of Amplitude-Modulated Radiofrequency: Molecular and Functional Synergies with Radiotherapy.

Cancers·2026
Same author

Fate of isoprene peroxy radical constrains the urban photochemical regime.

Science advances·2026
Same author

The Regulatory Interplay of the Colorectal Cancer Biomarkers MACC1 and IER2 and Its Impact on Metastatic Cancer Survival.

Biomolecules·2026
Same author

Copolymers of NVAm and NVP for Efficient Gene Delivery.

ACS polymers Au·2026

Novel suicide nanoplasmids, engineered for targeted delivery, effectively reduced neuroblastoma tumor growth in mice. This promising gene therapy approach demonstrated well-tolerated treatment with potential for pharmaceutical applications.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Nanotechnology

Background:

  • Conventional expression plasmids have large, non-essential DNA backbones.
  • Minicircle DNA technology reduces vector size but incurs high production costs.
  • Nanoplasmids offer a smaller DNA construct alternative with pharmaceutical potential.

Purpose of the Study:

  • To design and characterize novel suicide nanoplasmid constructs.
  • To evaluate the anti-proliferative activity and expression kinetics of these nanoplasmids.
  • To assess the therapeutic efficacy of suicide nanoplasmids in an in vivo neuroblastoma model.

Main Methods:

  • Designed suicide nanoplasmids encoding plant-derived ribosome-inactivating proteins.
  • Formulated nanoplasmids with a K16-lysine targeting domain.
Keywords:
Anti-tumorNanoplasmidSuicide gensToxins

Related Experiment Videos

  • Analyzed nanoplasmid size, characterized via electron microscopy, and assessed in vitro anti-proliferative activity and expression kinetics using EGFP.
  • Evaluated in vivo efficacy in a neuroblastoma mouse model.

    • Main Results:

    • Successfully designed and characterized novel suicide nanoplasmids.
    • Demonstrated in vitro anti-proliferative activity and determined expression kinetics.
    • Observed significant reduction in neuroblastoma tumor growth in treated mice.
    • Therapy was well-tolerated in vivo.

    Conclusions:

    • Suicide nanoplasmids are effective mini-DNA constructs for gene therapy.
    • Targeted nanoplasmid delivery shows potential for treating aggressive tumors like neuroblastoma.
    • This technology offers a cost-effective and well-tolerated therapeutic strategy.